• Anti-Pseudomonas aeruginosa serotype O11 LPS immunoglobulin M monoclonal antibody panobacumab (KBPA101) confers protection in a murine model of acute lung infection.
  T. Secher, L. Fauconnier, A. Szade, O. Rutschi, S.C. Fas, B. Ryffel, M.P. Rudolf.
  Journal of Antimicrobial Chemotherapy 2011, 66(5):1100-9.
  
• Opposite effect of HIF-1alpha and HIF-2alpha on regulation of IL-8 expression in endothelial cells.
  Urszula Florczyk, Szymon Czauderna, Anna Stachurska, Magdalena Tertil, Witold Nowak, Magdalena Kozakowska, Lorenz Poellinger, Alicja Jozkowicz, Agnieszka Loboda, Jozef Dulak
  Free Radic Biol Med. 2011; 51(10):1882-92.
  
• Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice.
  Was H, Sokolowska M, Sierpniowska A, Dominik P, Skrzypek K, Lackowska B, Pratnicki A, Grochot-Przeczek A, Taha H, Kotlinowski J, Kozakowska M, Mazan A, Nowak W, Muchova L, Vitek L, Ratajska A, Dulak J, Jozkowicz A
  Free Radic Biol Med. 2011; 51(9):1717-26.
  
• Stem Cells in Pharmaceutical Biotechnology.
  Zuba-Surma EK, Józkowicz A, Dulak J
  Curr Pharm Biotechnol. 2011 Sep 9.
  
• Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species.
  Szczepanek K, Chen Q, Derecka M, Salloum FN, Zhang Q, Szelag M, Cichy J, Kukreja RC, Dulak J, Lesnefsky EJ, Larner AC.
  J Biol Chem. 2011 Aug 26;286(34):29610-20
  
• Aristolochic acid I and ochratoxin A differentially regulate VEGF expression in porcine kidney epithelial cells--the involvement of SP-1 and HIFs transcription factors.
  Stachurska A, Kozakowska M, Jozkowicz A, Dulak J, Loboda A.
  Toxicol Lett. 2011 Jul 28;204(2-3):118-26
  
• CD45-CD14 +CD34 + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture.
  Szade K, Zuba-Surma E, Rutkowski AJ, Jozkowicz A, Dulak J.
  Mol Cells. 2011 Jun;31(6):497-507
  
• Pharmacological targeting of the transcription factor nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
  Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fernández-Ruiz J, Cuadrado A.
  Antioxid Redox Signal. 2011 Jun 15;14(12):2347-60. Epub 2011 Mar 28
  
• Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle.
  Karvinen H, Pasanen E, Rissanen TT, Korpisalo P, Vähäkangas E, Jazwa A, Giacca M, Ylä-Herttuala S.
  Gene Ther. 2011 Jun 9. doi: 10.1038/gt.2011.93. [Epub ahead of print]
  
• MicroRNAs as biomarkers of disease onset.
  Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A, Dulak J.
  Anal Bioanal Chem. 2011 May 6
  
• Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155
  Boesch-Saadatmandi C, Loboda A, Wagner AE, Stachurska A, Jozkowicz A, Dulak J, Doring F, WolfframS, Rimbach G.
  J Nutr Biochem. 2011;22(3):293-9
  
• Overexpression of biliverdin reductase enhances resistance to chemotherapeutics.
  Florczyk U, Golda S, Zieba A, Cisowski J, Jozkowicz A, Dulak J.
  Cancer Lett. 2011;300(1):40-7
  
• Expression of cellular retinoic acid-binding protein I and II (CRABP I and II) in embryonic mouse hearts treated with retinoic acid.
  Stachurska E, Loboda A, Niderla-Bielińska J, Szperl M, Juszyński M, Jozkowicz A, Dulak J, Ratajska A.
  Acta Biochim Pol. 2011;58(1):19-29
  

« 2010 | 2012 »